Browse: Departments Dates Agencies
SUBJECT CATEGORY: Notice of Issuance of Regulatory Guide
SUMMARY: Issuance and Availability of Regulatory Guide 6.1, Revision 2,
The U.S. Nuclear Regulatory Commission (NRC) has issued revisions to existing guides in the agency's ``Regulatory Guide'' series. This series was developed to describe and make available to the public information such as methods that are acceptable to the NRC staff for implementing specific parts of the agency's regulations, techniques that the staff uses in evaluating specific problems or postulated accidents, and data that the staff needs in its review of applications for permits and licenses.
Revision 2 of Regulatory Guide 6.1, ``Leak Testing Radioactive Brachytherapy Sources,'' was issued with a temporary identification as Draft Regulatory Guide DG6003. This guide directs the reader to methods and procedures acceptable to the staff of the NRC for leak testing radioactive brachytherapy sources. Possession and use of brachytherapy sources is an activity requiring a license pursuant to Title 10, section 30.3, ``Activities Requiring License,'' of the Code of Federal Regulations (10 CFR 30.3). The requirements in 10 CFR 35.67, ``Requirements for Possession of Sealed Sources and Brachytherapy Sources,'' state in part, that the sources are to be periodically leak tested and that the test be capable of detecting the presence of 185 becquerel (Bq) (0.005 microcurie ([mu]Ci)) of radioactive material in the sample. The regulations also require that the source be immediately withdrawn from use if the test reveals the presence of 185 Bq (0.005 [mu]Ci) or more of removable contamination.
This regulatory guide endorses the methods and procedures for leak testing radioactive brachytherapy sources contained in the current revisions of NUREG1556, Volume 3, ``Consolidated Guidance about Materials Licenses: Applications for Sealed Source and Device Evaluation and Registration'' and NUREG1556, Volume 9, ``Consolidated Guidance about Materials Licenses: ProgramSpecific Guidance about Medical Use Licenses'' as a process that the NRC staff has found to be acceptable for meeting the regulatory requirements.
In January 2008, DG6003 was published with a public comment period of 60 days from the issuance of the guide. No comments were received and the public comment period closed April 18, 2008. Electronic copies of Regulatory Guide 6.1, Revision 2 are available through the NRC's public Web site under ``Regulatory Guides'' at http://www.nrc.gov/ readingrm/doccollections/.
In addition, regulatory guides are available for inspection at the NRC's Public Document Room (PDR), which is located at Room O1F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852 2738. The PDR's mailing address is USNRC PDR, Washington, DC 20555 0001. The PDR can also be reached by telephone at (301) 4154737 or (800) 3974209, by fax at (301) 4153548, and by email to pdr@nrc.gov.
Regulatory guides are not copyrighted, and NRC approval is not required to reproduce them.
Dated at Rockville, Maryland, this 3rd day of July, 2008.
For the Nuclear Regulatory Commission.
Stephen C. O'Connor,
Acting Chief, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research.
[FR Doc. E815794 Filed 71008; 8:45 am]
BILLING CODE 759001P
FOR FURTHER INFORMATION CONTACT Mark Orr, Regulatory Guide Development Branch, Division of Engineering, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 205550001, telephone (301) 4156373 or email to Mark.Orr@nrc.gov.
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 50 CFR Part 679 47 CFR Part 73 26 CFR Part 1 40 CFR Part 180 33 CFR Part 117 50 CFR Part 17 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 33 CFR Part 100 40 CFR Part 63 50 CFR Part 622 44 CFR Part 65 50 CFR Part 660 26 CFR Part 301 39 CFR Part 111 40 CFR Part 300 6 CFR Part 5 40 CFR Part 271 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 44 CFR Part 64 10 CFR Part 50 49 CFR Part 571 47 CFR Part 76